Kolexia
Gressin Remy Hématologie
Gressin Remy
Hématologie
Hôpital Nord Grenoble
La Tronche, France
227 Activités
70 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome à cellules du manteau Lymphome B diffus à grandes cellules Lymphome B Tumeurs du système nerveux central Récidive tumorale locale Lymphome T Lymphome malin non hodgkinien Maladie de Hodgkin

Collaborateurs

Voir plus
Le Gouill Steven
Le Gouill Steven
Clcc Institut Curie, Paris, France
Gyan Emmanuel
Gyan Emmanuel
Centre hospitalier de Tours, Tours, France
Casasnovas Rene-Olivier
Casasnovas Rene-Olivier
Hôpital François Mitterrand, Dijon, France
Houot Roch
Houot Roch
Hôpital Pontchaillou, Rennes, France

Industries

Voir plus
Janssen
11 collaboration(s)
Dernière en 2023
B3TSI
6 collaboration(s)
Dernière en 2023
Incyte
2 collaboration(s)
Dernière en 2023
Abbvie
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
LyMa101: Phase II Study to Evaluate the Efficacy of Upfront Obinutuzumab in Mantle Cell Lymphoma Patients Treated by DHAP Followed by Autologous Transplantation Plus Obinutuzumab Maintenance Then MRD Driven Maintenance
Essai Clinique (The Lymphoma Academic Research Organisation)   13 mars 2024
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma.
Haematologica   22 février 2024
LOC-R01: Randomized Phase IB/II Study of Escalating Doses of Lenalidomide and Ibrutinib in Association With R-MPV as a Targeted Induction Treatment for Patients Aged 18 to 60 (up to 65 for Phase II) With a Newly Diagnosed Primary Central Nervous System Lymphoma
Essai Clinique (Institut Curie)   10 janvier 2024
Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   18 décembre 2023
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.
Haematologica   30 novembre 2023
Obinutuzumab Versus Rituximab in Transplant Eligible Untreated MCL Patients, a Matching Comparison between the Lyma and Lyma-101 Trials
65th ASH Annual Meeting Abstracts   02 novembre 2023
Combination Chemotherapy in Patients with Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCN): First Results of a Prospective French Trial (LpDessai)
65th ASH Annual Meeting Abstracts   02 novembre 2023
Optical Genome Mapping Provides New Molecular Insights in High-Risk Mantle Cell Lymphoma: A Lysa Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Validation of POD24 As a Robust Early Clinical End Point of Poor Survival in Mantle Cell Lymphoma from 1280 Patients on Clinical Trials
65th ASH Annual Meeting Abstracts   02 novembre 2023
Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort.
Blood advances   24 octobre 2023